Shinya Kimura
Department of Transfusion Medicine and Cell Therapy
Kyoto University Hospital
54 Kawahara-cho Shogoin
Sakyo-ku Kyoto 606-8507
Japan
Name/email consistency: high
- Second generation Abl kinase inhibitors and novel compounds to eliminate the Bcr-Abl/T315I clone. Kimura, S. Recent. Pat. Anticancer. Drug. Discov (2006)
- Inhibition of leukemic cell growth by a novel anti-cancer drug (GUT-70) from calophyllum brasiliense that acts by induction of apoptosis. Kimura, S., Ito, C., Jyoko, N., Segawa, H., Kuroda, J., Okada, M., Adachi, S., Nakahata, T., Yuasa, T., Filho, V.C., Furukawa, H., Maekawa, T. Int. J. Cancer (2005)
- NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia. Kimura, S., Naito, H., Segawa, H., Kuroda, J., Yuasa, T., Sato, K., Yokota, A., Kamitsuji, Y., Kawata, E., Ashihara, E., Nakaya, Y., Naruoka, H., Wakayama, T., Nasu, K., Asaki, T., Niwa, T., Hirabayashi, K., Maekawa, T. Blood (2005)
- Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines. Kimura, S., Kuroda, J., Segawa, H., Sato, K., Nogawa, M., Yuasa, T., Ottmann, O.G., Maekawa, T. Int. J. Hematol. (2004)
- Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. Kimura, S., Horie, A., Hiki, Y., Yamamoto, C., Suzuki, S., Kuroda, J., Deguchi, M., Kato, G., Karasuno, T., Hiraoka, A., Yoshikawa, T., Maekawa, T. Blood (2003)
